Business Context and Reporting Period
This Form 8-K Current Report was filed by Marathon Patent Group, Inc. (not MARA Holdings, Inc.) on November 22, 2013, covering events that occurred on November 18, 2013. The filing details the entry into material definitive agreements regarding executive compensation and the appointment of new officers.
Key Financial Metrics and Agreements
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it discloses specific compensatory arrangements and equity issuances:
- CEO Compensation (Doug Croxall): Employment term extended to November 14, 2017. Annual base salary increased to $480,000 with a 3% annual increase starting November 14, 2014. Granted a one-time cash bonus of $350,000 (50% payable within 3 days, 50% by February 1, 2014). Granted 100,000 stock options (10-year term, $5.93 strike price).
- CFO Compensation (Richard Raisig): Appointed effective December 3, 2013. Annual base salary of $250,000 with a potential annual bonus up to 100% of base salary. Granted 115,000 stock options (10-year term, $5.70 strike price, vesting over 24 months).
- Consulting Services (Jeff Feinberg): Granted 100,000 shares of restricted common stock for public relations services (50% vesting at 1 year, 50% at 2 years).
Material Changes Versus Prior Period
The filing reports significant changes in executive leadership and compensation structures compared to the prior period:
- Leadership Transition: John Stetson ceased serving as Chief Financial Officer effective December 3, 2013, moving to Executive Vice President. Richard Raisig was appointed as the new CFO.
- Compensation Increases: The CEO's base salary was increased, and a substantial cash bonus was authorized. New equity grants were issued to the CEO, new CFO, and a consultant.
- Equity Issuance: The company issued unregistered equity securities (stock options and restricted stock) totaling 215,000 shares/options to executives and consultants.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, financial outlook, or management commentary regarding future business performance. The primary risks and contingencies disclosed relate to:
- Executive Retention: The agreements are contingent upon continued employment for vesting of stock options.
- Regulatory Compliance: The issuance of securities was deemed exempt from registration under Section 4(2) of the Securities Act of 1933 as transactions not involving a public offering.
- Related Party Transactions: The filing confirms no material transactions exceeding $120,000 involving the new CFO since the beginning of the last fiscal year, other than the employment agreement.
Important Facts for Investor Verification
- Verify the exact vesting schedules and strike prices for the 215,000 total equity units granted to Croxall, Raisig, and Feinberg.
- Confirm the cash outflow impact of the $350,000 bonus to the CEO and the new salary obligations for the CFO.
- Review the full text of Exhibits 10.1, 10.2, and 10.3 for termination clauses and specific performance metrics tied to the bonus structures.
- Note that the company name in the filing is Marathon Patent Group, Inc., which may differ from the ticker symbol or common name used in other contexts.